John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GGP
1451
CALL
DELISTED
GGP Inc.
GGP
| $1.52M | 0.01% |
+51,100
| New | +$1.44M |
|
1452
PUT
Amgen
AMGN
$238B
| $1.52M | 0.01% |
10,000
+1,000
| +11% | +$155K |
|
1453
Cabot Corp
CBT
$4.37B
| $1.52M | 0.01% |
33,270
+18,056
| +119% | +$841K |
|
1454
LivePerson
LPSN
$33.4M
| $1.52M | 0.01% |
15,968
+9,724
| +156% | +$930K |
|
|
ESV
1455
PUT
DELISTED
Ensco Rowan plc
ESV
| $1.52M | 0.01% |
+39,050
| New | +$1.62M |
|
|
CMD
1456
DELISTED
Cantel Medical Corporation
CMD
| $1.51M | 0.01% |
+22,010
| New | +$1.52M |
|
|
RDC
1457
PUT
DELISTED
Rowan Companies Plc
RDC
| $1.51M | 0.01% |
+85,500
| New | +$1.48M |
|
1458
Griffon
GFF
$4.57B
| $1.51M | 0.01% |
89,370
+72,628
| +434% | +$1.18M |
|
1459
Stride
LRN
$3.52B
| $1.51M | 0.01% |
120,658
+78,795
| +188% | +$892K |
|
1460
PUT
Ameren
AEE
$29.8B
| $1.51M | 0.01% |
28,100
+6,700
| +31% | +$329K |
|
1461
Hawaiian Electric Industries
HE
$1.98B
| $1.51M | 0.01% |
45,917
+7,205
| +19% | +$237K |
|
1462
Atlassian
TEAM
$42.6B
| $1.5M | 0.01% |
57,971
+21,192
| +58% | +$502K |
|
1463
Sanmina
SANM
$10.6B
| $1.5M | 0.01% |
+55,896
| New | +$1.4M |
|
|
PXD
1464
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.5M | 0.01% |
+9,890
| New | +$1.55M |
|
1465
CALL
McKesson
MCK
$105B
| $1.49M | 0.01% |
8,000
+4,000
| +100% | +$702K |
|
|
NAVG
1466
DELISTED
Navigators Group Inc
NAVG
| $1.49M | 0.01% |
32,402
| – | – |
|
1467
CALL
Core Laboratories
CLB
$550M
| $1.49M | 0.01% |
+12,000
| New | +$1.45M |
|
|
SN
1468
DELISTED
Sanchez Energy Corporation
SN
| $1.48M | 0.01% |
+209,849
| New | +$1.62M |
|
1469
Five Below
FIVE
$14.2B
| $1.48M | 0.01% |
31,881
+20,078
| +170% | +$839K |
|
1470
Matrix Service
MTRX
$302M
| $1.48M | 0.01% |
89,753
+8,477
| +10% | +$143K |
|
1471
BorgWarner
BWA
$13.2B
| $1.48M | 0.01% |
56,916
+50,109
| +736% | +$1.52M |
|
|
SHLM
1472
DELISTED
Schulman (A.) Inc
SHLM
| $1.48M | 0.01% |
+60,582
| New | +$1.55M |
|
1473
Fortuna Silver Mines
FSM
$3.67B
| $1.46M | 0.01% |
210,132
-14,885
| -7% | -$86.6K |
|
|
BBG
1474
DELISTED
Bill Barrett Corp
BBG
| $1.46M | 0.01% |
228,931
+39,118
| +21% | +$286K |
|
1475
Stepan Co
SCL
$1.42B
| $1.46M | 0.01% |
24,523
-17,788
| -42% | -$1.04M |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.